27 C
New York
Wednesday, May 22, 2024

Merck’s stock rises on sales of its blockbuster cancer drug Keytruda

Related Content Merck is paying $10.8 billion for a company with no approved drugs Johnson & Johnson is reportedly eyeing its second big heart device company acquisition Merck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,177FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x